February 28, 2017 / 1:21 PM / in 9 months

BRIEF-Valeant reports Q4 adjusted eps of $1.26

Feb 28 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant reports fourth quarter and full year 2016 financial results and provides 2017 guidance

* Q4 revenue $2.403 billion versus I/B/E/S view $2.34 billion

* Reports FY 2016 adjusted (non-GAAP) earnings per share $5.47

* Reports Q4 2016 adjusted (non-GAAP) earnings per share $1.26

* Reports Q4 2016 GAAP loss per share $1.47

* Reports Q4 2016 revenue $2.4 billion

* Sees 2017 GAAP total revenues in range $8.90 billion - $9.10 billion

* Sees FY adjusted EBITDA in range of $3.55 billion - $3.70 billion Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below